Structural and Functional Characterization of Pontocerebellar Hypoplasia Associated Nucleases
Project Number3R00GM143534-04S1
Contact PI/Project LeaderHAYNE, CASSANDRA K
Awardee OrganizationUNIVERSITY OF CHICAGO
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
RNA processing is an essential cellular process that when dysregulated underlies the development of
neurological diseases. Several mutations in nuclease containing complexes cause pontocerebellar hypoplasia
(PCH), a severe neurological disorder that often leads to prenatal death. Most cases of PCH are linked to
mutations in the tRNA Splicing Endonuclease (TSEN) Complex, which is responsible for the cleavage of tRNA
introns prior to tRNA maturation, and its accessory protein, CLP1, which is a critical negative regulator of tRNA
splicing. Genetic deletion of any single TSEN protein in yeast, engineered to have tRNAs without introns, was
shown to be lethal, suggesting that the TSEN complex likely has substrates beyond the tRNAs, which may
underlie the development of PCH. Likewise, mutations in another nuclease, target of Egr 1 (TOE1), a
deadenylase and 3’-exonuclase, are also are linked to PCH. TOE1 is the only deadenylase believed to mature
snRNAs, but it also moonlights in other cellular pathways, highlighting how much is yet to understand about its
role in protein complexes.
To determine how mutations in TOE1, CLP1, and TSEN proteins lead to PCH, there remains a critical
need to understand how these complexes assemble, recognize and process RNAs, and how their enzymatic
activity is regulated. Characterizing healthy cellular roles of these proteins is essential to determining how their
dysfunction causes PCH. We aim to address these critical questions through the following proposed Aims. In
Aim 1, Structural and molecular techniques will be used to identify how the TSEN complex recognizes and
processes tRNAs and other RNA substrates. In Aim 2, we will determine how the CLP1/TSEN complex are
regulated at the molecular and cellular level and how PCH mutations disrupt their regulation. Further, in Aim 3,
we will identify how PCH mutations alter TOE1 function and regulation, using proteomics and molecular biology
approaches.
The proposed work is significant because it will provide a structural description for how known PCH
mutations may interfere with complex formation, stability, or function for a range of PCH-linked proteins. This
work will further provide insight into shared mechanisms by which these protein complexes cause PCH.
Furthermore, the work here will characterize new RNA processing roles for these nucleases.
Public Health Relevance Statement
PROJECT NARRATIVE
Pontocerebellar hypoplasia (PCH), a severe neurological disorder for which there is no cure that
is caused by mutations in several RNA processing complexes. The aims of this proposal will
determine how several PCH-linked complexes assemble, recognize and process RNA, how they
are enzymatically and spatially regulated, and how PCH mutations disrupt their function. This
work is essential to better understand how these complexes function normally in healthy states
and how their dysfunction leads to PCH.
No Sub Projects information available for 3R00GM143534-04S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R00GM143534-04S1
Patents
No Patents information available for 3R00GM143534-04S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R00GM143534-04S1
Clinical Studies
No Clinical Studies information available for 3R00GM143534-04S1
News and More
Related News Releases
No news release information available for 3R00GM143534-04S1
History
No Historical information available for 3R00GM143534-04S1
Similar Projects
No Similar Projects information available for 3R00GM143534-04S1